Prevalence of antibodies to human herpesvirus 8 (HHV-8) in saudi arabian patients with and without renal failure

被引:21
作者
Almuneef, M
Nimjee, S
Khoshnood, K
Miller, G
Rigsby, MO
机构
[1] Yale Coll, Dept Biol, W Haven, CT 06516 USA
[2] Yale Univ, Sch Med, Dept Internal Med, W Haven, CT 06516 USA
[3] Yale Univ, Sch Med, Dept Vet Affairs Connecticut Healthcare Syst, W Haven, CT 06516 USA
[4] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, W Haven, CT 06516 USA
[5] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, W Haven, CT 06516 USA
[6] Yale Univ, Sch Med, Dept Pediat, W Haven, CT 06516 USA
关键词
D O I
10.1097/00007890-200104270-00019
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Kaposi's sarcoma (KS) is the most common cancer occurring in renal transplant recipients in Saudi Arabia, where the reported incidence of posttransplantation KS is 10 times higher than the incidence in the United States and Western Europe, The reason for the particularly high incidence of posttransplantation KS in this geographic area is unknown, Methods. To explore the possibility that the high incidence of posttransplantation KS might be the result of widespread infection with human herpesvirus 8 (HHV-8), we determined the prevalence of antibodies to HHV-8 in 201 patients with end-stage renal disease (ESRD) and a comparison group of 358 individuals without renal disease who were similar in age, sex, and area of residence. Antibodies to lytic cycle antigens of HHV-8 were determined by indirect immunofluorescence and confirmed by immunoblots using tetradecanoyl phorbol ester acetate-induced BC-3 cell extracts and recombinant small viral capsid antigen (ORF65), Results. Antibodies to HHV-8 were detected in serum samples from 14 (6.97%) of 201 ESRD patients and from 10 (3.88%) of 258 in the comparison group (P=0.14) HHV-8 seropositive individuals were on average 10 years older than seronegative subjects (55.3 years vs. 46.9 years), Among HHV-8 seropositive subjects, 71% were male and 29% were female. Conclusions. Serologic evidence of HHV-8 infection was numerically more common in men and in patients with ERSD. However, among patients with and without ERSD, the strongest association was with increasing age.
引用
收藏
页码:1120 / 1124
页数:5
相关论文
共 17 条
[1]   Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus [J].
Arvanitakis, L ;
Mesri, EA ;
Nador, RG ;
Said, JW ;
Asch, AS ;
Knowles, DM ;
Cesarman, E .
BLOOD, 1996, 88 (07) :2648-2654
[2]  
Farge D, 1993, Eur J Med, V2, P339
[3]   KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma [J].
Gao, SJ ;
Kingsley, L ;
Li, M ;
Zheng, W ;
Parravicini, C ;
Ziegler, J ;
Newton, R ;
Rinaldo, CR ;
Saah, A ;
Phair, J ;
Detels, R ;
Chang, Y ;
Moore, PS .
NATURE MEDICINE, 1996, 2 (08) :925-928
[4]   Serologic and molecular evidence of human herpesvirus 8 activation in renal transplant recipients [J].
Hudnall, SD ;
Rady, PL ;
Tyring, SK ;
Fish, JC .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (06) :1791-1794
[5]   The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission [J].
Kedes, DH ;
Operskalski, E ;
Busch, M ;
Kohn, R ;
Flood, J ;
Ganem, D .
NATURE MEDICINE, 1996, 2 (08) :918-924
[6]   Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients [J].
Lennette, ET ;
Blackbourn, DJ ;
Levy, JA .
LANCET, 1996, 348 (9031) :858-861
[7]   Identification, expression, and immunogenicity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen [J].
Lin, SF ;
Sun, R ;
Heston, L ;
Gradoville, L ;
Shedd, D ;
Haglund, K ;
Rigsby, M ;
Miller, G .
JOURNAL OF VIROLOGY, 1997, 71 (04) :3069-3076
[8]   Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection [J].
Miller, G ;
Rigsby, MO ;
Heston, L ;
Grogan, E ;
Sun, R ;
Metroka, C ;
Levy, JA ;
Gao, SJ ;
Chang, Y ;
Moore, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (20) :1292-1297
[9]   Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma [J].
Moore, PS ;
Kingsley, LA ;
Holmberg, SD ;
Spira, T ;
Gupta, P ;
Hoover, DR ;
Parry, JP ;
Conley, LJ ;
Jaffe, HW ;
Chang, Y .
AIDS, 1996, 10 (02) :175-180
[10]  
PENN I, 1983, J CLIN LAB IMMUNOL, V12, P1